Analysts Set Astera Labs, Inc. (NASDAQ:ALAB) Price Target at $348.33

Astera Labs, Inc. (NASDAQ:ALAB) has been assigned an average rating of “Moderate Buy” from the twenty-one research firms that are currently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation, twelve have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $348.3333.

A number of equities research analysts recently issued reports on the stock. Bank of America upped their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Morgan Stanley raised their target price on Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target for the company in a research report on Monday, August 17th. TD Cowen decreased their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. Finally, UBS Group reissued a “neutral” rating and set a $425.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th.

Astera Labs Price Performance

NASDAQ ALAB opened at $291.22 on Monday. The stock has a market capitalization of $50.52 billion, a PE ratio of 144.17 and a beta of 3.77. The company has a 50 day moving average price of $316.60 and a two-hundred day moving average price of $261.10. Astera Labs has a 12-month low of $97.89 and a 12-month high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts anticipate that Astera Labs will post 2.7 EPS for the current year.

Insider Activity

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the transaction, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 592,244 shares of company stock valued at $209,729,973. Insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ALAB. Eurizon Capital SGR S.p.A. acquired a new stake in Astera Labs in the 4th quarter valued at approximately $18,708,000. Swedbank AB increased its position in Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after buying an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in shares of Astera Labs during the fourth quarter worth approximately $499,000. Revere Asset Management Inc acquired a new position in shares of Astera Labs during the fourth quarter worth approximately $589,000. Finally, Banque Cantonale Vaudoise boosted its position in shares of Astera Labs by 85.9% in the first quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after acquiring an additional 3,229 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.